Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03660631 · ClinicalTrials.gov registry record · NA
Dissemination of the Cardiovascular Risk Service
A NA study of Hypertension and Diabetes Mellitus, sponsored by Korey Kennelty.
- Active
- Registry status
- NA
- Development phase
- 542
- Enrollment target
- 14
- Study locations
NCT03660631: Active NA study of Hypertension and Diabetes Mellitus, sponsored by Korey Kennelty.
NCT03660631 is a NA study of Hypertension and Diabetes Mellitus that is active but no longer recruiting, run by Korey Kennelty. The registered enrollment target is 542 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (85% lower). The trial reports 14 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03660631, a NA study of Hypertension and Diabetes Mellitus, is active but no longer recruiting, sponsored by Korey Kennelty.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 542 participants
- Enrollment target
- 14
- Study locations
Study Summary
The objective of this study is to evaluate the implementation of of a remote, pharmacist-led cardiovascular risk service (CVRS) in 12 large, organizationally and culturally diverse hospitals and health-systems, many with high proportions of minority and underserved patients.
Conditions Studied
Interventions
- BEHAVIORAL CVRS Intervention
Study Locations (14)
Iowa
- Genesis Family Medical Center - Davenport
- University of Iowa - Iowa City
- UIHC River Crossing - Riverside
- Siouxland Family Medicine Center - Sioux City
- Northeast Iowa Family Practice Center - Waterloo
Illinois
- University of Illinois at Chicago: Mile Square Health Center - Chicago
- Carle Foundation Hospital - Mahomet
- Carle Foundation Hospital - Rantoul
Idaho
- Idaho State University - Pocatello
Michigan
- Henry Ford Health System: Harbortown - Detroit
North Carolina
- University of North Carolina - Chapel Hill
Pennsylvania
- Temple University - Philadelphia
Texas
- Texas Tech University Health Science Center - Amarillo
Washington
- Community Health Center of Snohomish County - Everett
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 542 participants |
| Start Date | 2018-09-27 |
| Est. Completion | 2024-12-30 |
| Phase | NA |
What the registry record for NCT03660631 still lists
NCT03660631 is an interventional study that assigns participants to a tested intervention. The registered 542 participants enrollment target is mid-sized for trials with a published cap, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (85% lower).
The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which CVRS Intervention is the first listed.
NCT03660631 lists 14 locations in 8 states (Iowa, Illinois, Idaho).
Frequently Asked Questions
What is clinical trial NCT03660631 about?
NCT03660631 is a clinical study titled "Dissemination of the Cardiovascular Risk Service". The objective of this study is to evaluate the implementation of of a remote, pharmacist-led cardiovascular risk service (CVRS) in 12 large, organizationally and culturally diverse hospitals and health-systems, many with high proportions of minority and underserved patients.
What is the current status of trial NCT03660631?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 542 participants. The study started on 2018-09-27. Estimated completion is 2024-12-30.
What conditions does trial NCT03660631 study?
This clinical trial studies the following conditions: Hypertension, Diabetes Mellitus.
What interventions are being tested in trial NCT03660631?
The interventions under investigation include: CVRS Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03660631?
This trial is sponsored by Korey Kennelty, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03660631 being conducted?
This trial has 14 study locations across Idaho, Illinois, Iowa, Michigan, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03660631's enrollment target sits among peer trials
542 110th of 470 higher than 360 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04929223 · 542 participants · Phase 1
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
- NCT05584670 · 542 participants · Phase 1
A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors
- NCT07294053 · 543 participants · NA
Sugary Drink Labeling Study
- NCT03127761 · 544 participants
Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI